[1] Pan XR, Yang WY, Li GW,et al.Prevalence of diabetes
and its risk factors in China,1994 [J]. National Diabetes
Prevention and Control Cooperative Group. Diabetes Care,
1997,20(11):1664-1669.
[2] Xu Y, Wang L, He J,etal. Prevalence and control of di-abetes in Chinese adults [J]. JAMA,2013,310(9):948-959.
[3] Egan BM, Zhao Y, Axon RN. US trends in prevalence,
awareness, treatment, and control of hypertension, 1988-2008[J]. JAMA, 2010,26,303(20):2043-2050.
[4] Alberti KG, Zimmet PZ. Definition, diagnosis and classifi-cation of diabetes mellitus and its complications. Part 1: di-agnosis and classification of diabetes mellitus provisional re-port of a WHO consultation [J]. Diabet Med, 1998,15(7):
539-553.
[5] Flink L, Underberg JA, Newman JD, et al. The recent
national lipid association recommendations: how do they
compare to other established dyslipidemia guidelines [J].
Curr Atheroscler Rep,2015,17(4):494.
[6] 国家心血管病中心.中国心血管病报告2015[M].北京:中国大百
科全书出版社,2016.
[7] 竺小芳.职业人群健康体检结果分析[J].预防医学与公共卫生,
2017,27(30):30-31.
[8] 许培培,张琳,杨帆,等.南京市某职业人群糖尿病患病现状及相
关危险因素[J].职业与健康,2017(13):1810-1813.
[9] Chen GY, Fan JG, Preva L, et al. Lence of and Risk
Factors for Type2 Diabetes Mellitus in Hyperlipidemia in
China [J]. Med Sci Monit,2015,22(21):2476-2484.
[10] Elmadhoun WM, Noor SK. Prevalence of diabetes melli-tus and its risk factors in urban communities of north Su-dan: Population based study [J]. J Diabetes, 2016,8(6):
839-846.
[11] Yang W, Lu J, Weng J,et al. Prevalence of diabetes
among men and women in China [J]. N Engl J Med,2010,
362(12):1090-1101.
[12] Cheung BM, Li C. Diabetes and hypertension: is there a
common metabolic pathway [J]. Curr AtherosclerRep,2012,
14(2):160-166.
[13] Gress TW, Nieto FJ. Hypertension and antihypertensive
therapy as risk factors for type 2 diabetes mellitus. Athero-sclerosis Risk in Communities Study [J]. N Engl JMed,2000,
342(13):905-912.
[14] Cheung BM. The hypertension- diabetes continuum [J]. J
Cardiovasc Pharmacol,2010,55(4):333-339.
[15] Reaven GM. Relationships among insulin resistance, type
2 diabetes, essential hypertension, and cardiovascular dis-ease: similarities and differences [J]. J Clin Hypertens
(Greenwich), 2011,13(4):238-243.
[16] Sung KC, Park HY, Kim MJ, et al. Metabolic markers
associated with insulin resistance predict type 2 diabetes in
Koreans with normal blood pressure or prehypertension [J].
Cardiovasc Diabetol,2016,15:47.